Kim Woojin Scott, Ordija Christine M, Freeman Mason W
Lipid Metabolism Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Biochem Biophys Res Commun. 2003 Oct 17;310(2):542-9. doi: 10.1016/j.bbrc.2003.09.049.
Macrophage scavenger class A type I and type II receptors (SR-A) are trimeric, integral membrane glycoproteins that bind an unusually broad array of macromolecular ligands. These ligands include modified proteins and lipoproteins, nucleic acids, and a variety of plant and microbial cell wall constituents, such as fucoidan and lipoteichoic acid. Early studies of SR-A functions indicated that the receptors bound, internalized, and degraded their ligands without provoking any macrophage activating signaling events. More recent studies have provided evidence that several SR-A ligands can activate macrophage gene expression via utilization of a receptor-linked, PI3-kinase pathway. To investigate the role of SR-A in engaging signal transduction events, we employed macrophages taken from mice lacking these receptors. Using either fucoidan or lipoteichoic acid, we confirm that both ligands stimulate tyrosine phosphorylation of PI3-kinase and production of modest levels of the cytokine, TNFalpha. However, macrophages taken from SR-A null mice did not differ from wild type macrophages in these responses, indicating that these signaling events arise independently of SR-A activity. Employing mice lacking CD14, a GPI anchored receptor that binds bacterial lipopolysaccharide and signals via activation of Toll-like receptors, we show that the fucoidan and lipoteichoic acid responses are largely abrogated when CD14 is absent. These data do not provide support for direct SR-A involvement in signal transduction events and suggest that the early characterization of these receptors as initiators of a non-phlogistic, pathogen clearance pathway was correct.
巨噬细胞清道夫A类I型和II型受体(SR-A)是三聚体整合膜糖蛋白,能结合种类异常广泛的大分子配体。这些配体包括修饰的蛋白质和脂蛋白、核酸,以及多种植物和微生物细胞壁成分,如岩藻依聚糖和脂磷壁酸。早期对SR-A功能的研究表明,这些受体结合、内化并降解其配体,而不会引发任何巨噬细胞激活信号事件。最近的研究提供了证据,表明几种SR-A配体可通过利用受体连接的PI3激酶途径激活巨噬细胞基因表达。为了研究SR-A在参与信号转导事件中的作用,我们使用了来自缺乏这些受体的小鼠的巨噬细胞。使用岩藻依聚糖或脂磷壁酸,我们证实这两种配体均刺激PI3激酶的酪氨酸磷酸化以及适度水平的细胞因子TNFα的产生。然而,来自SR-A基因敲除小鼠的巨噬细胞在这些反应中与野生型巨噬细胞没有差异,这表明这些信号事件独立于SR-A活性而产生。使用缺乏CD14的小鼠(CD14是一种糖基磷脂酰肌醇锚定受体,可结合细菌脂多糖并通过激活Toll样受体发出信号),我们发现当缺乏CD14时,岩藻依聚糖和脂磷壁酸反应在很大程度上被消除。这些数据不支持SR-A直接参与信号转导事件,并表明这些受体作为非炎症性病原体清除途径启动子的早期特征描述是正确的。